As of June 2, 2025, Makolab SA (MLB.WA) reports a ROE (Return on Equity) of 13.92%.
ROE (Return on Equity) measures how well a company generates profits from shareholders' investments, indicating equity efficiency.
Historical Trend of Makolab SA's ROE (Return on Equity)
Over recent years, Makolab SA's ROE (Return on Equity) has shown significant volatility. The table below summarizes the historical values:
| Date | ROE (Return on Equity) |
|---|---|
| 2024-12-31 | 13.92% |
| 2023-12-31 | 8.42% |
| 2022-12-31 | 15.05% |
| 2021-12-31 | 8.22% |
| 2020-12-31 | 22.66% |
This slight downward trend highlights how Makolab SA manages its efficiency in generating profits from shareholders' equity over time.
Comparing Makolab SA's ROE (Return on Equity) to Peers
To better understand Makolab SA's position, it's useful to compare its ROE (Return on Equity) against industry peers. Below are selected comparisons:
| Company | ROE (Return on Equity) |
|---|---|
| Makolab SA (MLB.WA) | 13.92% |
| Cloudcoco Group PLC (CLCO.L) | 150.72% |
| Generic Sweden AB (publ) (GENI.ST) | 49.35% |
| Ingenta PLC (ING.L) | 40.61% |
| Euroconsultants SA (EUROC.AT) | 39.97% |
| Novotek AB (NTEK B.ST) | 33.62% |
Compared to its competitors, Makolab SA's ROE (Return on Equity) is about average compared to peers, reflecting standard industry returns on equity investment.